Goss PE - Search Results

1

Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011.

Chavarri-Guerra Y, St Louis J, Bukowski A, Soto-Perez-de-Celis E, Liedke PER, Symecko H, Moy B, Higgins M, Finkelstein DM, Goss PE. Chavarri-Guerra Y, et al. Among authors: goss pe. Breast. 2017 Feb;31:197-201. doi: 10.1016/j.breast.2016.11.014. Epub 2016 Nov 25. Breast. 2017. PMID: 27894048

2

TEACH: Tykerb evaluation after chemotherapy.

Moy B, Goss PE. Moy B, et al. Among authors: goss pe. Clin Breast Cancer. 2007 Feb;7(6):489-92. doi: 10.3816/CBC.2007.n.007. Clin Breast Cancer. 2007. PMID: 17386127 No abstract available.

3

Breast cancer in Brazil: present status and future goals.

Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Lee BL, et al. Among authors: goss pe. Lancet Oncol. 2012 Mar;13(3):e95-e102. doi: 10.1016/S1470-2045(11)70323-0. Lancet Oncol. 2012. PMID: 22381937 Review.

4

Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective.

Chavarri-Guerra Y, St Louis J, Liedke PE, Symecko H, Villarreal-Garza C, Mohar A, Finkelstein DM, Goss PE. Chavarri-Guerra Y, et al. Among authors: goss pe. BMC Cancer. 2014 Sep 9;14:658. doi: 10.1186/1471-2407-14-658. BMC Cancer. 2014. PMID: 25199766 Free PMC article.

5

New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17.

Liedke PE, Tu D, Shepherd L, Chavarri-Guerra Y, Pritchard KI, Stearns V, Goss PE. Liedke PE, et al. Among authors: goss pe. Breast. 2016 Jun;27:99-104. doi: 10.1016/j.breast.2016.02.010. Epub 2016 Apr 5. Breast. 2016. PMID: 27058233 Clinical Trial.

6

Lapatinib: current status and future directions in breast cancer.

Moy B, Goss PE. Moy B, et al. Among authors: goss pe. Oncologist. 2006 Nov-Dec;11(10):1047-57. doi: 10.1634/theoncologist.11-10-1047. Oncologist. 2006. PMID: 17110623 Free article. Review.

7

Lapatinib-associated toxicity and practical management recommendations.

Moy B, Goss PE. Moy B, et al. Among authors: goss pe. Oncologist. 2007 Jul;12(7):756-65. doi: 10.1634/theoncologist.12-7-756. Oncologist. 2007. PMID: 17673607 Free article. Review.

8

Denosumab and the current status of bone-modifying drugs in breast cancer.

Lee BL, Higgins MJ, Goss PE. Lee BL, et al. Among authors: goss pe. Acta Oncol. 2012 Feb;51(2):157-67. doi: 10.3109/0284186X.2011.633555. Epub 2011 Dec 12. Acta Oncol. 2012. PMID: 22150116 Review.

9

Breast cancer in Mexico: a growing challenge to health and the health system.

Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, Knaul F, Mohar A, Finkelstein DM, Goss PE. Chávarri-Guerra Y, et al. Among authors: goss pe. Lancet Oncol. 2012 Aug;13(8):e335-43. doi: 10.1016/S1470-2045(12)70246-2. Lancet Oncol. 2012. PMID: 22846838 Review.

10

Extended adjuvant endocrine therapy in hormone dependent breast cancer: the paradigm of the NCIC-CTG MA.17/BIG 1-97 trial.

Higgins MJ, Liedke PE, Goss PE. Higgins MJ, et al. Among authors: goss pe. Crit Rev Oncol Hematol. 2013 Apr;86(1):23-32. doi: 10.1016/j.critrevonc.2012.09.013. Epub 2012 Oct 30. Crit Rev Oncol Hematol. 2013. PMID: 23116626 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters